Fundraising Fox
/Companies
Sign in

Avant Genomics

Charlottesville, US · Founded 2023 · 11 employees on LinkedIn · 5 known investors

Find your way into Avant Genomics

Sign up to see every warm intro you have to Avant Genomics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Avant Genomics team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Avant Genomics is developing an automated platform for liquid biopsy sample preparation, using an enclosed fluidic cartridge and benchtop instruments that integrate DNA enrichment and purification for blood-based cancer detection. The system targets research labs, clinical testing environments, and reference laboratories aiming to reduce manual labor and cost in precision oncology workflows.

BiotechHealthtechMedical Devices

Founders & leadership

Avant Genomics was founded in 2023 by Rachelle and Renna.

RRachelle
RachelleRachelle holds expertise in bioanalytical microfluidics and analytical chemistry, with background in developing integrated genetic systems for clinical diagnostics and forensic identification. As co-founder and CEO of Avant Genomics, she leads development of microfluidic technologies for blood-based cancer detection.
RRenna
RennaRenna Nouwairi holds a Ph.D. in bioanalytical chemistry and developed the core liquid biopsy technology during her doctoral and postdoctoral research at the University of Virginia. She is co-founder and COO of Avant Genomics, where she oversees operations, strategy, and cross-functional execution in microfluidics and analytical workflows for blood-based cancer detection.

Investors · 5

Virginia Venture Partners✓ confirmed by Avant GenomicsRichmond · $100K

How we know: the company's own site · clpmag.com · Not right? Tell us

Also in the syndicate · 3

CAV AngelsGlobal Impact FundHalyard Ventures

Funding

SEC filings, press & company announcements

$3M disclosed across 1 of 2 rounds · 2026

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Avant Genomics Secures $3M+ in Funding to Accelerate First-in-kind Automated Platform for Liquid Biopsy Sample Preparation - BioSpacebiospace.com · May 2026Avant Genomics Raises $3M+ in Fundingfinsmes.com · May 2026

Frequently asked questions

What does Avant Genomics do?
Avant Genomics is developing an automated platform for liquid biopsy sample preparation, using an enclosed fluidic cartridge and benchtop instruments that integrate DNA enrichment and purification for blood-based cancer detection. The system targets research labs, clinical testing environments, and reference laboratories aiming to reduce manual labor and cost in precision oncology workflows.
Who founded Avant Genomics?
Avant Genomics was founded by Rachelle, Renna in 2023.
Who are Avant Genomics's investors?
Avant Genomics's investors include TitletownTech, Virginia Venture Partners.
How much funding has Avant Genomics raised?
Avant Genomics has disclosed $3M raised across 1 of its 2 known rounds.
Where is Avant Genomics headquartered?
Avant Genomics is headquartered in Charlottesville, US.